中华肾脏病杂志
中華腎髒病雜誌
중화신장병잡지
2014年
8期
619-626
,共8页
张一婷%尹爱平%李利利%孙吉平
張一婷%尹愛平%李利利%孫吉平
장일정%윤애평%리리리%손길평
间质干细胞,骨髓%胰岛%Notch信号
間質榦細胞,骨髓%胰島%Notch信號
간질간세포,골수%이도%Notch신호
Mesenchymal stem cells%bone marrow%Islet of langerhans%Notch signaling
目的 通过Notch信号途径抑制剂DAPT构建Notch信号敲除模型,探讨Notch信号通路在骨髓间质干细胞(BMSCs)体外分化为胰岛样细胞中的作用.方法 体外分离培养BMSCs并鉴定,体外诱导其分化.用γ-分泌酶特异性抑制剂DAPT阻断Notch信号通路.采用双硫腙(DTZ)染色法鉴定胰岛细胞;间接免疫荧光染色,RT-PCR和Western印迹等方法检测诱导后细胞的胰岛素、胰高血糖素、胰十二指肠同源框1基因(Pdx-1)和神经元素3(Ngn3)的表达.ELISA法检测细胞葡萄糖刺激后分泌胰岛素水平.结果 (1)BMSCs鉴定:间接免疫荧光染色结果显示:BMSCs表达CD59和CD90抗原,体外可表达神经元特异性烯醇化酶(NSE)、神经胶质纤维酸性蛋白(GFAP)等神经细胞标记物,证实其具多向分化潜能.(2)MTT结果显示:γ-分泌酶抑制剂(DAPT)可抑制BMSCs增殖,其效应有时间和剂量依赖性.并以剂量和时间依赖性方式抑制Notch信号通路靶基因Hes1的表达.用1、5、20 μmol DAPT处理96 h后细胞的Hes1表达分别为对照组的92.06%、71.40%、46.89%,提示其对Notch信号通路阻断率分别达到7.94%、28.6%和53.11%(均P<0.05).(3)间接免疫荧光结果显示:DAPT阻断组的胰岛素和胰高血糖素阳性细胞百分比较对照组明显增多[分别为(74.03±3.96)%比(36.49±3.24)%;(64.81±4.37)%比(37.50±3.69)%,均P<0.05].提示阻断Notch信号通路后BMSCs体外分化效率增加.(4)RT-PCR和Western印迹结果提示:BSMCs诱导14 d后可以检测到胰岛素、胰高血糖素表达,DAPT阻断后上述蛋白表达上调;BMSCs诱导早期(7 d)即表达Pdx-1和Ngn3,14d后达到高峰,之后逐渐下降.DAPT阻断后Pdx-1和Ngn3的表达增加.(5)ELISA结果显示:诱导后细胞对葡萄糖刺激有分泌胰岛素反应,DAPT阻断后诱导细胞的反应更好.结论 大鼠BMSCs体外可分化为胰岛样细胞;阻断Notch信号通路可通过改变胰腺关键转录因子的表达而增强BMSCs体外分化能力.
目的 通過Notch信號途徑抑製劑DAPT構建Notch信號敲除模型,探討Notch信號通路在骨髓間質榦細胞(BMSCs)體外分化為胰島樣細胞中的作用.方法 體外分離培養BMSCs併鑒定,體外誘導其分化.用γ-分泌酶特異性抑製劑DAPT阻斷Notch信號通路.採用雙硫腙(DTZ)染色法鑒定胰島細胞;間接免疫熒光染色,RT-PCR和Western印跡等方法檢測誘導後細胞的胰島素、胰高血糖素、胰十二指腸同源框1基因(Pdx-1)和神經元素3(Ngn3)的錶達.ELISA法檢測細胞葡萄糖刺激後分泌胰島素水平.結果 (1)BMSCs鑒定:間接免疫熒光染色結果顯示:BMSCs錶達CD59和CD90抗原,體外可錶達神經元特異性烯醇化酶(NSE)、神經膠質纖維痠性蛋白(GFAP)等神經細胞標記物,證實其具多嚮分化潛能.(2)MTT結果顯示:γ-分泌酶抑製劑(DAPT)可抑製BMSCs增殖,其效應有時間和劑量依賴性.併以劑量和時間依賴性方式抑製Notch信號通路靶基因Hes1的錶達.用1、5、20 μmol DAPT處理96 h後細胞的Hes1錶達分彆為對照組的92.06%、71.40%、46.89%,提示其對Notch信號通路阻斷率分彆達到7.94%、28.6%和53.11%(均P<0.05).(3)間接免疫熒光結果顯示:DAPT阻斷組的胰島素和胰高血糖素暘性細胞百分比較對照組明顯增多[分彆為(74.03±3.96)%比(36.49±3.24)%;(64.81±4.37)%比(37.50±3.69)%,均P<0.05].提示阻斷Notch信號通路後BMSCs體外分化效率增加.(4)RT-PCR和Western印跡結果提示:BSMCs誘導14 d後可以檢測到胰島素、胰高血糖素錶達,DAPT阻斷後上述蛋白錶達上調;BMSCs誘導早期(7 d)即錶達Pdx-1和Ngn3,14d後達到高峰,之後逐漸下降.DAPT阻斷後Pdx-1和Ngn3的錶達增加.(5)ELISA結果顯示:誘導後細胞對葡萄糖刺激有分泌胰島素反應,DAPT阻斷後誘導細胞的反應更好.結論 大鼠BMSCs體外可分化為胰島樣細胞;阻斷Notch信號通路可通過改變胰腺關鍵轉錄因子的錶達而增彊BMSCs體外分化能力.
목적 통과Notch신호도경억제제DAPT구건Notch신호고제모형,탐토Notch신호통로재골수간질간세포(BMSCs)체외분화위이도양세포중적작용.방법 체외분리배양BMSCs병감정,체외유도기분화.용γ-분비매특이성억제제DAPT조단Notch신호통로.채용쌍류종(DTZ)염색법감정이도세포;간접면역형광염색,RT-PCR화Western인적등방법검측유도후세포적이도소、이고혈당소、이십이지장동원광1기인(Pdx-1)화신경원소3(Ngn3)적표체.ELISA법검측세포포도당자격후분비이도소수평.결과 (1)BMSCs감정:간접면역형광염색결과현시:BMSCs표체CD59화CD90항원,체외가표체신경원특이성희순화매(NSE)、신경효질섬유산성단백(GFAP)등신경세포표기물,증실기구다향분화잠능.(2)MTT결과현시:γ-분비매억제제(DAPT)가억제BMSCs증식,기효응유시간화제량의뢰성.병이제량화시간의뢰성방식억제Notch신호통로파기인Hes1적표체.용1、5、20 μmol DAPT처리96 h후세포적Hes1표체분별위대조조적92.06%、71.40%、46.89%,제시기대Notch신호통로조단솔분별체도7.94%、28.6%화53.11%(균P<0.05).(3)간접면역형광결과현시:DAPT조단조적이도소화이고혈당소양성세포백분비교대조조명현증다[분별위(74.03±3.96)%비(36.49±3.24)%;(64.81±4.37)%비(37.50±3.69)%,균P<0.05].제시조단Notch신호통로후BMSCs체외분화효솔증가.(4)RT-PCR화Western인적결과제시:BSMCs유도14 d후가이검측도이도소、이고혈당소표체,DAPT조단후상술단백표체상조;BMSCs유도조기(7 d)즉표체Pdx-1화Ngn3,14d후체도고봉,지후축점하강.DAPT조단후Pdx-1화Ngn3적표체증가.(5)ELISA결과현시:유도후세포대포도당자격유분비이도소반응,DAPT조단후유도세포적반응경호.결론 대서BMSCs체외가분화위이도양세포;조단Notch신호통로가통과개변이선관건전록인자적표체이증강BMSCs체외분화능력.
Objective To investigate the effect of Notch signaling during bone marrow mesenchymal stem cells (BMSC) differentiating into islet in vitro.Methods The specific inhibitor of γ-secretase DAPT was used to inhibit the Notch signaling pathway.Mter induction,DTZ staining,indirect immunofluorescence staining,RT-PCR and Westenn blotting were used to detect the expression of insulin,glucagon,Pdx-1 and Ngn3.Results (1) Identification of BMSCs:Indirect immunofluorescence staining showed that BMSCs could express CD59 and CD90,which both were makrers of mesenchymal stem cells.Besides,BMSCs could express nerve culluar markers such as NSE,GFAP,suggesting multi-directional differentiation.(2) The result of MTT showed DAPT could inhibit the cell proliferation in a time-dependent manner and a dose-dependent mannar.Besides,DAPT could inhibit the expression of target gene of Notch signal pathway in a time-dependent manner and a dosedependent mannar.After treated by 1,5,20 μmol DAPT,the expression of Hes1 had reached to 92.06%,71.40% and 46.89% of controls respectively,suggesting efficiency of inhibition on Notch reached 7.94%,28.6% and 53.11% respectively (all P< 0.05).(3) Indirect immunofluorescence staining showed the expression of pancreas-specific markers such as insulin and glucagon were much higher in DAPT treated BMSCs than that in controls,which was confirmed by RT-PCR and Western blotting analyses.The proportion of insulin-producing cells differentiated from DAPT treated BMSCs was (74.03 ± 3.96)%,which was higher than that from controls[(36.49 ± 3.24)%,P< 0.05].(4)Furthermore,RT-PCR and Western blotting analysis showed that the expressions of Pdx-1 and Ngn3 were earlier than that of insulin and glucagon,and the expressions of Pdx-1 and Ngn3 were higher in DAPT treated BMSCs than that in controls.Conclusions Notch signaling pathway plays a role in the differentiation of BMSCs into islet in vitro.Pharmacological interference with Notch signaling pathway may provide a novel method to obtain islet for therapeutic use.